CSU research teams work on coronavirus vaccine


This is an archived article and the information in the article may be out of date. Please look at the timestamp on the story to see when it was last updated.

FORT COLLINS, Colo. (KDVR) – Colorado State University (CSU) has research teams working on four coronavirus vaccine development projects:

  • Use of a modified bacterium
  • A combination of light and vitamin B2
  • A modified poxvirus used against smallpox
  • A vaccine platform against tuberculosis

Mary Jackson, a professor in the Department of Microbiology, Immunology and Pathology at Colorado State University, is leading a new research project looking at a tuberculosis vaccine platform to see if it could be effective in the fight against COVID -19.

The platform, Bacillus Calmette-Guerin (BCG), is a widely used vaccine to prevent tuberculosis worldwide.

“Countries that practice universal BCG vaccination appear to have fewer COVID-19 cases and lower death rates,” Jackson said in an interview with CSU news platform SOURCE.

“In general, it appears that the vaccine somehow prepares the immune system to better protect people of all ages against a wide range of diseases caused by bacteria, fungi or viruses.”


Comments are closed.